Neurocrine (NBIX) presented new data from the long-term, open-label KINECT 4 study demonstrating remission of tardive dyskinesia among the ...
Exeter Innovation is a partner for transformative innovation. We harness the world leading research and education of the University of Exeter to create real and lasting impact, by working with ...